Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ong Corp 418.85 5.50
Hindalco 146.25 2.34
Axis Ban 417.70 3.92
Reliance 934.50 0.23
Tata Stl 450.15 0.54
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Suven Life Sciences Limited
Suven Life Sciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530239NSE:SUVENBloomberg:SVLS@INReuters:SUVP.BO
Market Lot: 1Face Value: 1ISIN Demat: INE495B01038
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
13-OCT-14 Suven Life Sciences, a biopharmaceutical company, announces today that its drug discovery portfolio which has expanded into several new therapeutic areas such as Major Depressive Disorder (MDD), Obesity and Pain through Neuronal Nicotinic Receptor modulators resulted in the grant of one product patent from USA (8735423) and one product patent from South Korea (10-1410903). 07-OCT-14 Suven Life sciences (Suven) announces today that Su...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Suven secures two product patents in South Korea and USA  -IRIS 13-Oct-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1415.325103.122578.85
Other Income10.7930.3010.43
Total Income1426.115133.422589.28
Cost of goods sold836.502912.542046.99
OPBDIT589.612220.88542.29
PAT347.381441.58308.40
Gross Block---
Equity capital116.83116.83116.83
EPS (Rs.)-12.342.64
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-1.78 - 6.765.09 - 13.35
Debt / Equity (x)---
Operating margin (% of OI)41.343.320.9
Net margin (% of OI)24.428.111.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
SDE Serene Chambers
Road No 5
Banjara Hills
Hyderabad
Andhra Pradesh-500 034
PHONE
(040) 2354 1142/ 3311
FAX
(040) 2354 1152
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer